ºÝºÝߣshows by User: BerndLiedert / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: BerndLiedert / ºÝºÝߣShare feed for ºÝºÝߣshows by User: BerndLiedert https://cdn.slidesharecdn.com/profile-photo-BerndLiedert-48x48.jpg?cb=1565351898 Familiar with both sides of the table, the developers´ objectives and the regulators´ perspective on biopharmaceutical drug development: Just started as Sr.Clinical Program Leader at Boehringer Ingelheim, Global Dept. Biosimilars Business. For more than 6 years Head of Immunopharmacology at Merck Serono and scientific/regulatory adviser for Merck Serono´s initial Biosimilar projects. Involved in numerous Merck Serono Due Diligence evaluations, providing independent view on risks, value and strategic fit of external opportunities. Seasoned consultant at the FORUM Institute for Management: Sharing my expert knowledge with executives from innovator and biosimilars industry, as well...